Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SLC2A1 |
| Upstream (Parents) |
|---|
| (<<) ADM → SLC2A1 |
| (<<) ANKRD37 → SLC2A1 |
| (<<) GAPT → SLC2A1 |
| (<<) SPINK1 → SLC2A1 |
| (<<) RLF → SLC2A1 |
| Downstream (Children) |
|---|
| SLC2A1 → IL1RAP (>>) |
| SLC2A1 → STC2 (>>) |
| SLC2A1 → NDRG1 (>>) |
| SLC2A1 → ADM (>>) |
| SLC2A1 → FGF11 (>>) |
| SLC2A1 → ANKRD37 (>>) |
| SLC2A1 → EDN2 (>>) |
| SLC2A1 → C4orf47 (>>) |
| SLC2A1 → PFKFB3 (>>) |
| SLC2A1 → CSPG4 (>>) |
| SLC2A1 → HK2 (>>) |
| SLC2A1 → SPINK1 (>>) |
| SLC2A1 → CA9 (>>) |
| SLC2A1 → RLF (>>) |
